Insider Title Company Date Price Return Shares Value
Stenhouse Mark Chief Operating Officer Prometheus Biosciences, Inc. (RXDX) 2021-03-16 $19.00 952.2% 14,000 $266,000
Return Profit / (loss) Cost
Total 952.2% $2,532,880 $266,000